                         SEQUENCE LISTING

<110>  BioNTech SE
 
<120>  POTENCY ASSAY FOR THERAPEUTIC POTENTIAL OF CODING NUCLEIC ACID

<130>  674-420 PCT

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Secretion sequence

<400>  1

Met Arg Val Met Ala Pro Arg Thr Leu Ile Leu Leu Leu Ser Gly Ala 
1               5                   10                  15      


Leu Ala Leu Thr Glu Thr Trp Ala Gly Ser 
            20                  25      


<210>  2
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MITD

<400>  2

Ile Val Gly Ile Val Ala Gly Leu Ala Val Leu Ala Val Val Val Ile 
1               5                   10                  15      


Gly Ala Val Val Ala Thr Val Met Cys Arg Arg Lys Ser Ser Gly Gly 
            20                  25                  30          


Lys Gly Gly Ser Tyr Ser Gln Ala Ala Ser Ser Asp Ser Ala Gln Gly 
        35                  40                  45              


Ser Asp Val Ser Leu Thr Ala 
    50                  55  


<210>  3
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2P16

<400>  3

Lys Lys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu 
1               5                   10                  15      


Leu Lys Lys Leu Gly Gly Gly Lys Arg Gly Gly Gly Lys Lys Met Thr 
            20                  25                  30          


Asn Ser Val Asp Asp Ala Leu Ile Asn Ser Thr Lys Ile Tyr Ser Tyr 
        35                  40                  45              


Phe Pro Ser Val Ile Ser Lys Val Asn Gln Gly Ala Gln Gly Lys Lys 
    50                  55                  60                  


Leu 
65  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GS Linker

<400>  4

Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
1               5                   10  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GS Linker

<400>  5

Gly Ser Ser Gly Gly Gly Gly Ser Pro Gly Gly Gly Ser Ser 
1               5                   10                  


<210>  6
<211>  47
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  5'-UTR

<400>  6
aacuaguauu cuucuggucc ccacagacuc agagagaacc cgccacc                     47


<210>  7
<211>  278
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  3'-UTR

<400>  7
cugguacugc augcacgcaa ugcuagcugc cccuuucccg uccuggguac cccgagucuc       60

ccccgaccuc gggucccagg uaugcuccca ccuccaccug ccccacucac caccucugcu      120

aguuccagac accucccaag cacgcagcaa ugcagcucaa aacgcuuagc cuagccacac      180

ccccacggga aacagcagug auuaaccuuu agcaauaaac gaaaguuuaa cuaagcuaua      240

cuaaccccag gguuggucaa uuucgugcca gccacacc                              278


<210>  8
<211>  110
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  A30L70

<400>  8
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa gcauaugacu aaaaaaaaaa aaaaaaaaaa       60

aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa                 110


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2

<400>  9

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15  


<210>  10
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P16

<400>  10

Met Thr Asn Ser Val Asp Asp Ala Leu Ile Asn Ser Thr Lys Ile Tyr 
1               5                   10                  15      


Ser Tyr Phe Pro Ser Val Ile Ser Lys Val Asn Gln Gly Ala Gln Gly 
            20                  25                  30          


<210>  11
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MITD7-28

<400>  11

Gly Gly Ser Tyr Ser Gln Ala Ala Ser Ser Asp Ser Ala Gln Gly Ser 
1               5                   10                  15      


Asp Val Ser Leu Thr Ala 
            20          


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 1

<400>  12

Phe Ile Gly Ile Thr Glu Leu Lys 
1               5               


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 3

<400>  13

Ile Tyr Ser Tyr Phe Pro Ser Val Ile Ser Lys 
1               5                   10      


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-02

<400>  14

Ala Gly Phe Ala Gly Asp Asp Ala Pro Arg 
1               5                   10  


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-06

<400>  15

Ile Gly Pro Leu Gly Leu Ser Pro Lys 
1               5                   


<210>  16
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-07

<400>  16

Thr Thr Pro Ser Tyr Val Ala Phe Thr Asp Thr Glu Arg 
1               5                   10              


<210>  17
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-11

<400>  17

Ser Tyr Glu Leu Pro Asp Gly Gln Val Ile Thr Ile Gly Asn Glu Arg 
1               5                   10                  15      


<210>  18
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-12

<400>  18

Tyr Phe Pro Thr Gln Ala Leu Asn Phe Ala Phe Lys 
1               5                   10          


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CiRT-14

<400>  19

Asp Ser Thr Leu Ile Met Gln Leu Leu Arg 
1               5                   10  


<210>  20
<211>  239
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  eGFP construct

<400>  20

Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu 
1               5                   10                  15      


Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly 
            20                  25                  30          


Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile 
        35                  40                  45              


Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr 
    50                  55                  60                  


Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys 
65                  70                  75                  80  


Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu 
                85                  90                  95      


Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu 
            100                 105                 110         


Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly 
        115                 120                 125             


Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr 
    130                 135                 140                 


Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn 
145                 150                 155                 160 


Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser 
                165                 170                 175     


Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly 
            180                 185                 190         


Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu 
        195                 200                 205             


Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe 
    210                 215                 220                 


Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys 
225                 230                 235                 


